TrumpRx finally launches with limited prescription drug discounts

President Trump unveiled TrumpRx, a government website listing cash-only discounts on 43 brand-name drugs; discounts apply only to out-of-pocket purchases and cannot be used with insurance.

President Trump unveiled TrumpRx on Thursday, a government website that lists discounts on brand-name prescription drugs for people who pay cash rather than use health insurance. The launch follows an executive order and months of negotiation with drugmakers after a delayed rollout. The White House said it struck agreements with several manufacturers to lower prices and exempt them from certain tariffs in exchange for price commitments. TrumpRx does not sell drugs directly; it links to manufacturers' sites or provides coupons to use at pharmacies. Key facts: - Forty-three brand-name drugs were listed at launch, supplied by five companies: AstraZeneca, Eli Lilly, EMD Serono, Novo Nordisk and Pfizer. - Reported discounts range from roughly 33% (for Pfizer's Xeljanz) to about 93% (for EMD Serono's Cetrotide); some discounts are hardship-only or mirror offers already available elsewhere. - Prices on TrumpRx apply only to out-of-pocket cash purchases for brand-name drugs; generics and insurance use are excluded. - About 92% of Americans have health insurance, and the site notes that insurance co-pays may be lower and that purchases made through TrumpRx may not count toward deductibles or annual out-of-pocket maximums. - The White House said 11 additional companies will offer discounts through TrumpRx in the coming months. Summary: The launch creates a new channel for out-of-pocket savings on a limited set of brand-name drugs, which may help people without insurance or those whose plans do not cover certain medications. The program's immediate reach is limited by the small number of drugs at launch and the requirement to pay cash rather than use insurance. The administration says more manufacturers will join in the coming months.